These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17637573)

  • 1. Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies.
    Muhamuda K; Madhusudana SN; Ravi V
    Hum Vaccin; 2007; 3(5):192-5. PubMed ID: 17637573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency.
    Turki I; Hammami A; Kharmachi H; Mousli M
    Mol Immunol; 2014 Feb; 57(2):66-73. PubMed ID: 24091293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity.
    Bakker AB; Python C; Kissling CJ; Pandya P; Marissen WE; Brink MF; Lagerwerf F; Worst S; van Corven E; Kostense S; Hartmann K; Weverling GJ; Uytdehaag F; Herzog C; Briggs DJ; Rupprecht CE; Grimaldi R; Goudsmit J
    Vaccine; 2008 Nov; 26(47):5922-7. PubMed ID: 18804136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of Recombinant Human Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis].
    Sun L; Liu Y; Li C; Li D; Liang M
    Bing Du Xue Bao; 2016 Jul; 32(4):399-403. PubMed ID: 29979531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of reducing rabies immunoglobulin dosage for passive immunization against rabies: results of In vitro and In vivo studies.
    Madhusudana SN; Ashwin BY; Sudarshan S
    Hum Vaccin Immunother; 2013 Sep; 9(9):1914-7. PubMed ID: 23792347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure.
    Champion JM; Kean RB; Rupprecht CE; Notkins AL; Koprowski H; Dietzschold B; Hooper DC
    J Immunol Methods; 2000 Feb; 235(1-2):81-90. PubMed ID: 10675760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabbit anti-rabies immunoglobulins production and evaluation.
    Liu X; Liu Q; Feng X; Tang Q; Wang Z; Li S; Feng Z; Zhu J; Guan X
    Trop Biomed; 2011 Apr; 28(1):138-48. PubMed ID: 21602780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies.
    Chao TY; Ren S; Shen E; Moore S; Zhang SF; Chen L; Rupprecht CE; Tsao E
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006133. PubMed ID: 29261658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies.
    Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C
    Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the rapid fluorescent focus inhibition test for rabies virus-neutralizing antibodies in clinical samples.
    Kostense S; Moore S; Companjen A; Bakker AB; Marissen WE; von Eyben R; Weverling GJ; Hanlon C; Goudsmit J
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3524-30. PubMed ID: 22547629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody.
    Dietzschold B; Tollis M; Rupprecht CE; Celis E; Koprowski H
    J Infect Dis; 1987 Nov; 156(5):815-22. PubMed ID: 3655404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and diagnostic use of a novel recombinant single-chain antibody against rabies virus glycoprotein.
    Yuan R; Chen X; Chen Y; Gu T; Xi H; Duan Y; Sun B; Yu X; Jiang C; Liu X; Wu C; Kong W; Wu Y
    Appl Microbiol Biotechnol; 2014 Feb; 98(4):1547-55. PubMed ID: 24241896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.
    Goudsmit J; Marissen WE; Weldon WC; Niezgoda M; Hanlon CA; Rice AB; Kruif Jd; Dietzschold B; Bakker AB; Rupprecht CE
    J Infect Dis; 2006 Mar; 193(6):796-801. PubMed ID: 16479514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice.
    Kaur M; Saxena A; Rai A; Bhatnagar R
    FASEB J; 2010 Jan; 24(1):173-83. PubMed ID: 19741168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein.
    Sun L; Chen Z; Yu L; Wei J; Li C; Jin J; Shen X; Lv X; Tang Q; Li D; Liang M
    Appl Microbiol Biotechnol; 2012 Oct; 96(2):357-66. PubMed ID: 22678022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of rabies virus strains used for vaccine production by means of monoclonal antibodies.
    Sureau P; Rollin P; Lafon M
    Dev Biol Stand; 1984; 57():227-31. PubMed ID: 6084613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.
    Um J; Chun BC; Lee YS; Hwang KJ; Yang DK; Park JS; Kim SY
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006084. PubMed ID: 29267277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous human rabies immunoglobulin for post-exposure prophylaxis: serum rabies neutralizing antibody concentrations and side-effects.
    Aoki FY; Rubin ME; Friesen AD; Bowman JM; Saunders JR
    J Biol Stand; 1989 Jan; 17(1):91-104. PubMed ID: 2646301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis.
    De Benedictis P; Minola A; Rota Nodari E; Aiello R; Zecchin B; Salomoni A; Foglierini M; Agatic G; Vanzetta F; Lavenir R; Lepelletier A; Bentley E; Weiss R; Cattoli G; Capua I; Sallusto F; Wright E; Lanzavecchia A; Bourhy H; Corti D
    EMBO Mol Med; 2016 Apr; 8(4):407-21. PubMed ID: 26992832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovine anti-rabies antibody production and evaluation.
    Redwan el-RM; Fahmy A; El Hanafy A; Abd El-Baky N; Sallam SM
    Comp Immunol Microbiol Infect Dis; 2009 Jan; 32(1):9-19. PubMed ID: 18242705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.